Overexpression of HDAC2 was highly correlated with high tumor grade, positive lymph node status, and dismal prognosis, and the HDAC inhibitor showed antitumor effects on breast cancer lines by mediation of miR‐182 (Shan et al., 2017). Here, HDAC2 is linked to breast carcinoma.